3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain
2
Neoplasms
2
Multiple Myeloma
2
Breast Carcinoma In Situ
2
Adenomatous Polyposis Coli
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Monoclonal Gammopathy of Undetermined Significance
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Condylomata Acuminata
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
97
Filgrastim
92
Etoposide
91
Dexamethasone
89
Mycophenolic Acid
70
Doxorubicin
70
Whole-Body Irradiation
66
Mercaptopurine
66
Tacrolimus
64
Busulfan
64
Radiotherapy
63
Cyclosporine
61
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Curcumin
×
Clear all
NCT05045443
2024-01-08
CurcumPedALL
Ain Shams University
Phase 2
Completed
30 enrolled